rs2015343

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_000275.3(OCA2):c.1045-3508T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.603 (AC=91,581) in the gnomAD database across 151,994 control chromosomes, including 31,789 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.789. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 31789 hom., cov: 32)

Consequence

OCA2
NM_000275.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.502

Publications

3 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • oculocutaneous albinism
    Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000275.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.7893 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000275.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCA2
NM_000275.3
MANE Select
c.1045-3508T>C
intron
N/ANP_000266.2Q04671-1
OCA2
NM_001300984.2
c.1045-4489T>C
intron
N/ANP_001287913.1Q04671-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OCA2
ENST00000354638.8
TSL:1 MANE Select
c.1045-3508T>C
intron
N/AENSP00000346659.3Q04671-1
OCA2
ENST00000353809.9
TSL:1
c.1045-4489T>C
intron
N/AENSP00000261276.8Q04671-2
OCA2
ENST00000910120.1
c.1045-3508T>C
intron
N/AENSP00000580179.1A0ACI8R8E8

Frequencies

GnomAD3 genomes
AF:
0.603
AC:
91582
AN:
151876
Hom.:
31794
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.274
Gnomad AMI
AF:
0.771
Gnomad AMR
AF:
0.573
Gnomad ASJ
AF:
0.716
Gnomad EAS
AF:
0.397
Gnomad SAS
AF:
0.371
Gnomad FIN
AF:
0.839
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.795
Gnomad OTH
AF:
0.639
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.603
AC:
91581
AN:
151994
Hom.:
31789
Cov.:
32
AF XY:
0.600
AC XY:
44567
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.274
AC:
11361
AN:
41450
American (AMR)
AF:
0.573
AC:
8741
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.716
AC:
2480
AN:
3466
East Asian (EAS)
AF:
0.397
AC:
2041
AN:
5142
South Asian (SAS)
AF:
0.370
AC:
1776
AN:
4794
European-Finnish (FIN)
AF:
0.839
AC:
8881
AN:
10586
Middle Eastern (MID)
AF:
0.769
AC:
226
AN:
294
European-Non Finnish (NFE)
AF:
0.795
AC:
54034
AN:
67972
Other (OTH)
AF:
0.633
AC:
1339
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1439
2878
4317
5756
7195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.673
Hom.:
4940
Bravo
AF:
0.576
Asia WGS
AF:
0.457
AC:
1590
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.420
AC:
51538
AN:
122778
Turkish Variome
AF:
0.710
AC:
1097
AN:
1546
Hom.:
385
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.373
AC:
3338
AN:
8960
Hom.:
630
ABraOM SABE-WGS-1171
AF:
0.623
AC:
1459
AN:
2342
Hom.:
465

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
3.5
DANN
Benign
0.67
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.